Advik Laboratories bulk deals, insider trading and stake changes
BSE: 531686Pharmaceuticals & BiotechnologySmall Cap
Last close ₹2.08₹0.00 (0.00%)
Share price at the BSE close on 19 Oct 2026. Previous close ₹2.08.
52-week range of traded prices to 19 Oct 2026
₹1.57Low, 2 Mar 2026₹2.08High, 15 Sep 2026
- Under BSE's graded surveillance, stage IV, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹3.98 Cr5,167th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 28 May 2026
- 58.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- −180.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- −14.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 28 May 2026
- 109.84
- Volume, BSEVolume. Shares traded on the last trading day.
- 300
Advik Laboratories insider trading
All 11 disclosures on record. The company's own latest disclosure on record is from Nov 2022.Insider trading, all companies
Nov 2022
- VIKAS LIFECARE LIMITED₹0.61 Cr33,47,325 sharesGave · Connected Person · 7 Nov 2022 · disclosed 9 Nov · Off Market · held 33,47,325 before, holds none after
Jun 2022
- VIKAS LIFECARE LIMITED8,65,000sharesSold · Connected Person · 20 Jun 2022 · disclosed 22 Jun · stake 22.04% before, 17.51% after
Mar 2021
- OMKAM PHARMACEUTICALS PRIVATE LIMITED₹3.32 Cr37,81,147 sharesReleased · Promoter · 11 Mar 2021 · disclosed 13 Mar · Revocation of Pledge · stake 25.65% before, 25.65% after
- PEEYUSH KUMAR AGGARWAL0sharesReleased · Promoter Group · 11 Mar 2021 · disclosed 13 Mar · Revocation of Pledge · stake 10.24% before, 10.24% after
Jun 2019
- OMKAM PHARMACEUTICALS PRIVATE LIMITED₹0.17 Cr11,00,000 sharesPledged · Promoter · 24 Jun 2019 · Pledge Creation · stake 25.65% before, 25.65% after
Feb 2017
- Omkam Pharmaceuticals Pvt Ltd₹3.32 Cr37,81,147 sharesPledged · Promoter · 17 Feb 2017 · Pledge · stake 25.65% before, 25.65% after
Aug 2015
- Omkam Pharmaceuticals Pvt Ltd9,590sharesGave · Promoter · 28 Aug 2015 · Market · held 49,11,912 before
- Omkam Pharmaceuticals Pvt Ltd10,000sharesGave · Promoter · 24 Aug 2015 · Market · held 49,21,912 before
- Omkam Pharmaceuticals Pvt Ltd1,43,900sharesGave · Promoter · 17 Aug 2015 · disclosed 21 Aug · Market · held 50,65,812 before
Earlier, May 2015 to May 2015Hide earlier
May 2015
- Omkam Pharmaceuticals Pvt Ltd11,21,175sharesReceived · Promoter · 15 May 2015 · disclosed 19 May · Preferential Offer · held 39,44,637 before
- Peeyush K Aggarwal11,21,175sharesReceived · Director · 15 May 2015 · disclosed 19 May · Preferential Offer · held 8,35,984 before
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Advik Laboratories stake sales and purchases
All 26 disclosures on record.
Nov 2022
- SoldVikas Lifecare Ltd · promoter17.51% of the company33,47,325 shares7 Nov 2022 · filed under the 2% rule · Off Market
- AcquiredPatliputra International Ltd17.51% of the company33,47,325 sharesholds 17.51% after7 Nov 2022 · filed under the 2% rule · Off Market
Jun 2022
- SoldVikas Lifecare Ltd · promoter4.53% of the company8,65,000 sharesholds 17.51% after20 Jun 2022 · filed under the 2% rule · Market
Jul 2021
- AcquiredVikas Lifecare Ltd22.04% of the company42,12,325 sharesholds 22.04% after12 Jul 2021 · filed under the 5% rule · Market
- SoldPatliputra International Ltd13.76% of the company26,29,000 shares12 Jul 2021 · filed under the 2% rule · Market
- SoldDhiru Builders & Promoters Pvt Ltd8.40% of the company16,05,270 shares12 Jul 2021 · filed under the 2% rule · Off Market
- SoldDhiru Builders & Promoters Pvt Ltd8.40% of the company16,05,270 sharesholds 5.23% after12 Jul 2021 · filed under the 2% rule · Off Market
Nov 2019
- AcquiredS Sangeetha6.71% of the company12,82,992 sharesholds 6.71% after1 Nov 2019 · filed under the 5% rule · Off Market
- SoldP Subramanian6.71% of the company12,82,992 shares1 Nov 2019 · filed under the 2% rule · Off Market
Oct 2016
- SoldS Sangeetha6.13% of the company11,73,302 shares10 Oct 2016 · filed under the 2% rule · Off Market
- AcquiredP Subramanian6.14% of the company11,73,302 sharesholds 6.71% after10 Oct 2016 · filed under the 5% rule · Off Market
May 2015
- AcquiredPeeyush K Aggarwal & Omkam Pharmaceuticals Pvt Ltd · promoter11.73% of the company22,42,350 sharesholds 36.75% after15 May 2015 · filed under the 2% rule · Conversion of warrants
- AcquiredPatliputra International Ltd4.81% of the company9,20,150 sharesholds 13.76% after15 May 2015 · filed under the 2% rule · Conversion of warrants
- AcquiredDhiru Builders & Promoters Pvt Ltd4.81% of the company9,20,150 sharesholds 13.76% after15 May 2015 · filed under the 2% rule · Conversion of warrants
Earlier, Jun 2007 to Nov 2013Hide earlier
Nov 2013
- AcquiredPeeyush K Aggarwal & Omkam Pharmaceuticals Pvt Ltd · promoter15.02% of the company22,57,650 sharesholds 31.81% after21 Nov 2013 · filed under the 2% rule · Preferential allotment
- AcquiredPeeyush K Aggarwal · promoter5.32% of the company8,00,000 sharesholds 8,35,984 shares after21 Nov 2013 · filed under the 5% rule · Preferential allotment
- AcquiredDhiru Builders & Promoters Pvt Ltd11.37% of the company17,08,850 sharesholds 11.37% after21 Nov 2013 · filed under the 5% rule · Preferential allotment
- AcquiredPatliputra International Ltd11.37% of the company17,08,850 sharesholds 11.37% after21 Nov 2013 · filed under the 5% rule · Preferential allotment
Apr 2013
- SoldVarinder Kr Jain & Others · promoter26.51% of the company24,79,237 sharesholds 0.06% after4 Apr 2013 · filed under the 2% rule · Open Offer
- AcquiredOmkam Pharmaceuticals Pvt Ltd · promoter26.51% of the company24,79,237 sharesholds 26.51% after4 Apr 2013 · filed under the 5% rule · SPA & Open Offer
Nov 2012
- AcquiredS Sangeetha & PACs0.09% of the company9,000 sharesholds 10.81% after26 Nov 2012 · filed under the 5% rule · Market
Nov 2011
- AcquiredV K Jain HUF · promoter3.40% of the company3,17,887 sharesholds 3.47% after15 Nov 2011 · filed under the 2% rule · Inter-se Transfer
- SoldDivya Jain · promoter3.40% of the company3,17,887 shares15 Nov 2011 · filed under the 2% rule · Inter-se Transfer
Sep 2007
- AcquiredSURESH BOHRA & PAC1.16% of the company1,08,890 sharesholds 8.16% after15 Sep 2007
Jun 2007
- AcquiredSURESH BOHRA0.75% of the company69,714 shares22 Jun 2007
- AcquiredSURESH BOHRA0.75% of the company69,714 sharesholds 4.10% after22 Jun 2007
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Advik Laboratories bulk deals
None in the last 12 months, since 23 Oct 2025.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Monday 20 Jun 20223 firms · ₹0.12 Cr bought · ₹0.14 Cr soldNet sold ₹0.02 Cr
- SoldVIKAS LIFECARE LIMITEDSold 8,65,000 at ₹1.594.53% of the company₹0.14 Cr
- BoughtSNEHA GARGBought 3,85,000 at ₹1.592.01% of the company₹0.06 Cr
- BoughtGEETA GARGBought 3,80,000 at ₹1.591.99% of the company₹0.06 Cr
Monday 12 Jul 20212 firms · ₹0.02 Cr bought · ₹0.02 Cr soldNet nil
- SoldPATLIPUTRA INTERNATIONAL LIMITEDSold 2,21,945 at ₹1.111.16% of the company₹0.02 Cr
- BoughtVIKAS LIFECARE LIMITEDBought 2,00,000 at ₹1.111.05% of the company₹0.02 Cr
Thursday 18 May 20172 firms · ₹0.12 Cr bought · ₹0.07 Cr soldNet bought ₹0.05 Cr
- BoughtZUBER TRADING LLPBought 2,11,859 at ₹5.761.11% of the company₹0.12 Cr
- SoldETHAN CONSTRUCTIONS PRIVATE LIMITEDSold 1,21,279 at ₹5.800.63% of the company₹0.07 Cr
Thursday 31 Dec 20152 firms · ₹0.15 Cr bought · ₹0.20 Cr soldNet sold ₹0.05 Cr
- SoldNIRVANA MALL MANAGEMENT CO PVT LTDSold 1,64,900 at ₹12.000.86% of the company₹0.20 Cr
- BoughtMAGAN MERCANTILE PVT LTDBought 1,23,900 at ₹11.990.65% of the company₹0.15 Cr
Tuesday 24 Jul 20122 firms · ₹0.05 Cr bought · ₹0.08 Cr soldNet sold ₹0.03 Cr
- SoldSNEHALATHA SINGHISold 1,00,000 at ₹7.92₹0.08 Cr
- BoughtSAMPARK SECURITIES PRIVATE LIMITEDBought 65,234 at ₹7.85₹0.05 Cr
Tuesday 4 Oct 20111 firm · ₹0 bought · ₹0.02 Cr soldNet sold ₹0.02 Cr
- SoldVINEET SINHASold 47,492 at ₹4.14₹0.02 Cr
Monday 3 Oct 20111 firm · ₹0 bought · ₹0.03 Cr soldNet sold ₹0.03 Cr
- SoldVINEET SINHASold 67,969 at ₹4.35₹0.03 Cr
Wednesday 28 Sep 20111 firm · ₹0.04 Cr bought · ₹0 soldNet bought ₹0.04 Cr
- BoughtVINEET SINHABought 78,257 at ₹5.06₹0.04 Cr
Thursday 30 Jun 20111 firm · ₹0 bought · ₹0.03 Cr soldNet sold ₹0.03 Cr
- SoldSANA PASRICHASold 69,971 at ₹3.70₹0.03 Cr
Monday 7 Jan 20081 firm · ₹0 bought · ₹0.17 Cr soldNet sold ₹0.17 Cr
- SoldBETA STOCK BROKERSSold 1,02,500 at ₹16.51₹0.17 Cr
Thursday 3 Jan 20081 firm · ₹0.09 Cr bought · ₹0 soldNet bought ₹0.09 Cr
- BoughtM KIRAN KUMARBought 50,000 at ₹17.50₹0.09 Cr
Wednesday 2 Jan 20081 firm · ₹0 bought · ₹0.19 Cr soldNet sold ₹0.19 Cr
- SoldBETA STOCK BROKERSold 1,15,000 at ₹16.70₹0.19 Cr
Monday 17 Dec 20072 firms · ₹0 bought · ₹0.14 Cr soldNet sold ₹0.14 Cr
- SoldBETA STOCK BROKERSSold 61,800 at ₹12.66₹0.08 Cr
- SoldSJM INVESTMENT DELHI PVT LTDSold 48,200 at ₹12.65₹0.06 Cr
Friday 14 Sep 20071 firm · ₹0.06 Cr bought · ₹0 soldNet bought ₹0.06 Cr
- BoughtBHASKAR SAHARANBought 62,263 at ₹10.01₹0.06 Cr
Friday 27 Jul 20071 firm · ₹0.04 Cr bought · ₹0 soldNet bought ₹0.04 Cr
- BoughtNEERAJ BHATIABought 50,000 at ₹8.04₹0.04 Cr
Friday 29 Jun 20071 firm · ₹0.06 Cr bought · ₹0 soldNet bought ₹0.06 Cr
- BoughtBETA STOCK BROKERSBought 62,570 at ₹9.06₹0.06 Cr
Thursday 28 Jun 20071 firm · ₹0.06 Cr bought · ₹0 soldNet bought ₹0.06 Cr
- BoughtBETA STOCK BROKERSBought 62,570 at ₹9.06₹0.06 Cr
Monday 25 Jun 20071 firm · ₹0.05 Cr bought · ₹0 soldNet bought ₹0.05 Cr
- BoughtBETA STOCK BROKERSBought 61,047 at ₹8.70₹0.05 Cr
Friday 22 Jun 20071 firm · ₹0.06 Cr bought · ₹0 soldNet bought ₹0.06 Cr
- BoughtBETA STOCK BROKERSBought 69,714 at ₹8.26₹0.06 Cr
Thursday 10 May 20071 firm · ₹0.08 Cr bought · ₹0 soldNet bought ₹0.08 Cr
- BoughtBETA STOCK BROKERBought 90,000 at ₹8.68₹0.08 Cr
Tuesday 8 May 20071 firm · ₹0.09 Cr bought · ₹0.05 Cr soldNet bought ₹0.04 Cr
- Both waysBETA STOCK BROKERBought 1,07,422 at ₹8.59Sold 58,122 at ₹8.40Net +49,300 shares₹0.09 Cr bought
Monday 7 May 20072 firms · ₹0.14 Cr bought · ₹0.11 Cr soldNet bought ₹0.03 Cr
- Both waysBETA STOCK BROKERSBought 82,419 at ₹8.83Sold 59,900 at ₹8.99Net +22,519 shares₹0.07 Cr bought
- Both waysJMP SECURITIES PVT. LTD.Bought 76,951 at ₹9.05Sold 63,393 at ₹9.04Net +13,558 shares₹0.07 Cr bought
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 33 deals on record from 4 Jan 2004.